interactions:
- request:
    body: retmax=1000&db=pubmed&retmode=xml&api_key=<omitted>&id=10357793&id=20358181&id=6355494&id=8998951&id=3383337
    headers:
      Accept:
      - application/json
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      Content-Length:
      - '135'
      Content-Type:
      - application/x-www-form-urlencoded
      User-Agent:
      - hawc
    method: POST
    uri: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi
  response:
    body:
      string: '<?xml version="1.0" ?>

        <!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January
        2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">

        <PubmedArticleSet>

        <PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10357793</PMID><DateCompleted><Year>1999</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>1999</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Hepatic
        hyperplasia and cancer in rats: alterations in copper metabolism.</ArticleTitle><Pagination><StartPage>1091</StartPage><EndPage>1096</EndPage><MedlinePgn>1091-6</MedlinePgn></Pagination><Abstract><AbstractText>We
        previously demonstrated that rats exposed to the peroxisome proliferator (PP)
        diethylhexylphthalate (DEHP) had reduced serum ceruloplasmin (CP) oxidase
        activity, which suggests tissue copper deposition. Copper is highly toxic
        in excess, and results in cellular damage and hepatocellular carcinomas (HCC).
        This study addresses changes in expression of copper-related genes and metal
        accumulation in hyperplastic liver and tumors induced by PP. Male rats were
        fed diets containing DEHP or clofibrate (CLF) for 3-60 days (hyperplasia)
        and 4-chloro-6-(2,3 xylidino)-2-pyrimidinyl-thio(N-beta-hydroxyethyl) acetamide
        for 10 months (HCC). During hyperplasia, an immediate and progressive decrease
        in serum CP activity was observed (P &lt; 0.05), as were reductions in mRNA
        levels for both CP and Wilson''s disease gene (WD gene, a P-type ATPase) (P
        &lt; 0.05). Tumor-bearing rats had lower serum CP activity (P &lt; 0.05),
        and CP and WD gene mRNA levels were reduced in tumors (P &lt; 0.05), and in
        liver surrounding tumors (SL) (P &lt; 0.05). Metallothionein mRNA showed no
        consistent changes during hyperplasia. Tumors showed a 2.5-fold induction
        of metallothionein mRNA (P &lt; 0.05), and a 1.2-fold increase in SL. Temporal
        increases in liver copper content occurred during hyperplasia, with increases
        of 2-fold (DEHP) and 3.3-fold (CLF) at 60 days (P &lt; 0.05). Copper content
        was 2.2-fold higher in tumors (P &lt; 0.05) and 1.7-fold higher in SL; iron
        did not increase and zinc decreased temporally. Thus, copper accumulation
        and changes in copper-related gene expression may be contributing factors
        in liver neoplasia in PP-treated rats. Loss of CP results in decreased free
        radical scavenger capacity and thus may enhance oxidative damage induced by
        PPs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eagon</LastName><ForeName>P
        K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>VA Medical
        Center, Pittsburgh, PA 15240, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Teepe</LastName><ForeName>A G</ForeName><Initials>AG</Initials></Author><Author
        ValidYN="Y"><LastName>Elm</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author><Author
        ValidYN="Y"><LastName>Tadic</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author><Author
        ValidYN="Y"><LastName>Epley</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author
        ValidYN="Y"><LastName>Beiler</LastName><ForeName>B E</ForeName><Initials>BE</Initials></Author><Author
        ValidYN="Y"><LastName>Shinozuka</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Rao</LastName><ForeName>K N</ForeName><Initials>KN</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA53453</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>53PF01Q249</RegistryNumber><NameOfSubstance
        UI="D002995">Clofibric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>789U1901C5</RegistryNumber><NameOfSubstance
        UI="D003300">Copper</NameOfSubstance></Chemical><Chemical><RegistryNumber>9038-94-2</RegistryNumber><NameOfSubstance
        UI="D008668">Metallothionein</NameOfSubstance></Chemical><Chemical><RegistryNumber>969LVT6GJ2</RegistryNumber><NameOfSubstance
        UI="C016908">pirinixil</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.16.3.1</RegistryNumber><NameOfSubstance UI="D002570">Ceruloplasmin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002570" MajorTopicYN="N">Ceruloplasmin</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002995" MajorTopicYN="N">Clofibric Acid</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003300" MajorTopicYN="N">Copper</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006965" MajorTopicYN="N">Hyperplasia</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008668" MajorTopicYN="N">Metallothionein</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>6</Month><Day>5</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>6</Month><Day>5</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10357793</ArticleId><ArticleId IdType="doi">10.1093/carcin/20.6.1091</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">20358181</PMID><DateCompleted><Year>2011</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0738</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>85</Volume><Issue>1</Issue><PubDate><Year>2011</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>26-Week
        carcinogenicity study of di-isodecyl phthalate by dietary administration to
        CB6F1-rasH2 transgenic mice.</ArticleTitle><Pagination><StartPage>59</StartPage><EndPage>66</EndPage><MedlinePgn>59-66</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1007/s00204-010-0536-6</ELocationID><Abstract><AbstractText>This
        study examined the carcinogenic potential of di-isodecyl phthalate (DIDP)
        in rasH2 mice. DIDP was administered to 15 rasH2 mice/gender/group at dietary
        levels of 0, 0.1, 0.33, or 1% and 15 wild-type mice/gender/group at dietary
        levels of 0 and 1% for 26 weeks. Non-neoplastic changes were observed in the
        liver (parenchymal inflammation, fatty changes, diffuse hepatocyte hypertrophy
        with eosinophilic granules and focal necrosis) and kidneys (tubular basophilia
        and tubular hyperplasia) after administration of DIDP in the rasH2 and wild-type
        mice. In the neoplastic lesions, there were a higher number of hepatocellular
        adenomas in the male rasH2 mice receiving 1% DIDP, compared with the findings
        in the liver of control rasH2 mice or wild-type mice. The incidence of hepatocellular
        adenomas in the 0.1, 0.33, and 1% DIDP exposed rasH2 mice was 7% (1/15), 7%
        (1/15), and 33% (5/15), respectively. This study adds a set of results for
        an additional test chemical for the performance of the rasH2 short-term transgenic
        model to the existing database of 3 compounds (WY-14643, DEHP, and clofibrate)
        tested in the ILSI/HESI ACT project.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Wan-Seob</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Centre
        for Inflammation Research, The Queen''s Medical Research Institute, The University
        of Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Jayoung</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Choi</LastName><ForeName>Mina</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Park</LastName><ForeName>Sue Nie</ForeName><Initials>SN</Initials></Author><Author
        ValidYN="Y"><LastName>Han</LastName><ForeName>Beom Seok</ForeName><Initials>BS</Initials></Author><Author
        ValidYN="Y"><LastName>Son</LastName><ForeName>Woo-Chan</ForeName><Initials>WC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2010</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>684-93-5</RegistryNumber><NameOfSubstance
        UI="D008770">Methylnitrosourea</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical><Chemical><RegistryNumber>WF93T741QI</RegistryNumber><NameOfSubstance
        UI="C042080">diisodecyl phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D018248" MajorTopicYN="N">Adenoma, Liver Cell</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015197" MajorTopicYN="N">Carcinogenicity Tests</DescriptorName><QualifierName
        UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011905" MajorTopicYN="N">Genes, ras</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008770" MajorTopicYN="N">Methylnitrosourea</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2009</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2010</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2010</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2010</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2011</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">20358181</ArticleId><ArticleId IdType="doi">10.1007/s00204-010-0536-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6355494</PMID><DateCompleted><Year>1983</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0098-4108</ISSN><JournalIssue
        CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>1983</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal
        of toxicology and environmental health</Title><ISOAbbreviation>J Toxicol Environ
        Health</ISOAbbreviation></Journal><ArticleTitle>The carcinogenicity of di(2-ethylhexyl)
        phthalate (DEHP) in perspective.</ArticleTitle><Pagination><StartPage>159</StartPage><EndPage>169</EndPage><MedlinePgn>159-69</MedlinePgn></Pagination><Abstract><AbstractText>The
        commonly used plasticizer di(2-ethylhexyl) phthalate (DEHP) was recently tested
        for chronic toxic potential by incorporation into the diet of rats and mice
        for approximately 2 yr. Upon reviewing the test results, the sponsoring organization
        concluded that DEHP was carcinogenic to the rats and mice, as indicated by
        increased occurrences of liver tumors in the DEHP-exposed animals in comparison
        to controls. Another group has disagreed with this conclusion, however, citing
        perceived methodological deficiencies and improper interpretations in the
        study, and has also suggested that rodents may not be adequate models of human
        response to DEHP. This communication compares the conduct of the DEHP bioassay
        favorably with state-of-the-art procedures in animal carcinogenicity testing
        and documents approval of the study interpretations by several independent
        peer review groups. The carcinogenic potential of DEHP is placed in perspective
        by evaluating the evidence for DEHP-induced tumors in rodent species in light
        of dose response relationships, other biochemical and toxicological effects
        of DEHP, and its comparative metabolism and disposition in rodent and primate
        species. A composite analysis of the currently available information indicates
        that DEHP has been shown to be carcinogenic to rodents in a valid chronic
        test, indicating that it should be considered as a potential carcinogen in
        humans, as well. Further experimental inquiry will be required, however, to
        accurately assess the potential health risks posed to humans by exposure to
        small amounts of this plasticizer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Kluwe</LastName><ForeName>W M</ForeName><Initials>WM</Initials></Author><Author
        ValidYN="Y"><LastName>Haseman</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author
        ValidYN="Y"><LastName>Huff</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>J Toxicol Environ Health</MedlineTA><NlmUniqueID>7513622</NlmUniqueID><ISSNLinking>0098-4108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008452" MajorTopicYN="N">Maximum Allowable Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008722" MajorTopicYN="N">Methods</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009374" MajorTopicYN="N">Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>35</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1983</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1983</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1983</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6355494</ArticleId><ArticleId IdType="doi">10.1080/15287398309530414</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8998951</PMID><DateCompleted><Year>1997</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>09</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0272-0590</ISSN><JournalIssue
        CitedMedium="Print"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>1996</Year><Month>May</Month></PubDate></JournalIssue><Title>Fundamental
        and applied toxicology : official journal of the Society of Toxicology</Title><ISOAbbreviation>Fundam
        Appl Toxicol</ISOAbbreviation></Journal><ArticleTitle>Oncogenicity testing
        of 2-ethylhexanol in Fischer 344 rats and B6C3F1 mice.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>41</EndPage><MedlinePgn>29-41</MedlinePgn></Pagination><Abstract><AbstractText>2-Ethylhexanol
        (2EH) is a weak nongenotoxic hepatic peroxisome proliferator in the rat. It
        is a high-volume chemical intermediate in the preparation of the plasticizers
        bis-(2-ethylhexyl) adipate (DEHA), bis-(2-ethylhexyl) phthalate (DEHP), and
        tris-(2-ethylhexyl) phosphate (TEHP), which are weak hepatocellular tumorigens
        in female mice. In consequence, the oncogenic potential of 2EH was evaluated
        in male (M) and female (F) rats and mice (50 animals/sex/group). Oral gavage
        doses of 2EH in 0.005% aqueous Cremophor EL (polyoxyl-35 castor oil) were
        given five times a week to rats: 0 (water), 0 (vehicle), 50, 150, and 500
        mg/kg for 24 months, and to mice: 0 (water), 0 (vehicle), 50, 200, and 750
        mg/kg for 18 months. Statistical comparisons of data were made between vehicle
        controls and treatment groups. There were no differences of biological significance
        between data from vehicle and water control groups. In rats, there were no
        dose-related changes at 50 mg/kg. There was reduced body weight gain at 150
        mg/kg (M, 16; F, 12%) and 500 mg/kg (M, 33; F, 31%) and an increased incidence
        of lethargy and unkemptness. There were dose-related increases in relative
        liver, stomach, brain, kidney, and testis weights at sacrifice. Female rat
        mortality was markedly increased at 500 mg/kg. There was marked aspiration-induced
        bronchopneumonia in rats at 500 mg/kg; hematologic, gross, and microscopic
        changes, including tumors, were otherwise comparable among all rat groups.
        In mice at 50 and 200 mg/kg there were no dose-related changes and essentially
        no time-dependent or time-independent adverse trends in liver tumor incidence
        at the 5% significance level. At 750 mg/kg mouse body weight gain was reduced
        (M, 26; F, 24%), and mortality increased (M and F, 30%) versus vehicle controls.
        At 750 mg/kg there was a slight increase in nonneoplastic focal hyperplasia
        in the forestomach of mice (M 5/50, F 4/50) versus vehicle controls (M 1/50,
        F 1/50). There were increases in mouse relative liver (F, 21%) and stomach
        (M, 13%; F, 19%) weights at 750 mg/kg. There was a 12% incidence of hepatic
        basophilic foci and an 18% incidence of hepatocellular carcinomas in male
        mice at 750 mg/kg, not statistically significant compared with either control
        by Fisher''s exact test. There was a 12% incidence of hepatic basophilic foci
        and a 10% incidence of hepatocellular carcinomas in female mice at 750 mg/kg,
        statistically significant (p &lt; 0.05) compared with vehicle but not with
        water controls by Fisher''s exact test. There were no metastases. Time-dependent
        and -independent statistical analyses showed an adverse trend in the incidence
        of hepatocellular carcinomas in male and female mice, correlated with toxicity
        (expressed as mortality) at 750 mg/kg. The time-adjusted incidence of hepatocellular
        carcinomas in male mice (18.8%) was within the historical normal range at
        the testing facility (0-22%), but that in females (13.1%) lay outside the
        normal range (0-2%). Under the conditions of these studies 2EH was not oncogenic
        in rats, but there were weak adverse trends in hepatocellular carcinoma incidence
        in mice at high dose levels which may have been associated with toxicity.
        The major effects of chronic dosing were mortality in female rats at 500 mg/kg
        and in male and female mice at 750 mg/kg, accompanied by reductions in body
        weight gain in rats at 150 and 500 mg/kg and in mice at 750 mg/kg. Direct
        comparison of any tumorogenic effects of 2EH given alone to female mice with
        those due to 2EH formed in vivo from DEHA, DEHP, or TEHP is limited by the
        high mortality caused by 2ER in female mice at equivalent doses of 2EH. While
        2EH may be a contributing factor in the hepatocellular carcinogenesis in female
        mice associated with the chronic administration of DEHA and DEHP, it is unlikely
        to be the entire proximate carcinogen.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Astill</LastName><ForeName>B
        D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Toxicology
        Research Task Group, Chemical Manufacturers Association, Washington, DC 20037,
        USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gingell</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Guest</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Hellwig</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Hodgson</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author
        ValidYN="Y"><LastName>Kuettler</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Mellert</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author
        ValidYN="Y"><LastName>Murphy</LastName><ForeName>S R</ForeName><Initials>SR</Initials></Author><Author
        ValidYN="Y"><LastName>Sielken</LastName><ForeName>R L</ForeName><Initials>RL</Initials><Suffix>Jr</Suffix></Author><Author
        ValidYN="Y"><LastName>Tyler</LastName><ForeName>T R</ForeName><Initials>TR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Fundam Appl Toxicol</MedlineTA><NlmUniqueID>8200838</NlmUniqueID><ISSNLinking>0272-0590</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000441">Hexanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014677">Pharmaceutical Vehicles</NameOfSubstance></Chemical><Chemical><RegistryNumber>XZV7TAA77P</RegistryNumber><NameOfSubstance
        UI="C034017">2-ethylhexanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001772" MajorTopicYN="N">Blood Cell Count</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015197" MajorTopicYN="N">Carcinogenicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000441" MajorTopicYN="N">Hexanols</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007441" MajorTopicYN="N">Intubation, Gastrointestinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014677" MajorTopicYN="N">Pharmaceutical Vehicles</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1996</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1996</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8998951</ArticleId><ArticleId IdType="doi">10.1006/faat.1996.0073</ArticleId><ArticleId
        IdType="pii">S0272059096900731</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3383337</PMID><DateCompleted><Year>1988</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>9</Volume><Issue>7</Issue><PubDate><Year>1988</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Failure
        of the peroxisome proliferator WY-14,643 to induce unscheduled DNA synthesis
        in rat hepatocytes following in vivo treatment.</ArticleTitle><Pagination><StartPage>1179</StartPage><EndPage>1183</EndPage><MedlinePgn>1179-83</MedlinePgn></Pagination><Abstract><AbstractText>Peroxisome
        proliferator hepatocarcinogens lack genotoxic activity in numerous in vitro
        assays using non-target cells which do not respond with peroxisome proliferation.
        Therefore, the effect of in vivo treatment with WY-14,643 on DNA repair was
        quantitated in rat hepatocytes, the target cell for carcinogenesis. Palmitoyl
        CoA oxidase and carnitine acetyltransferase activities in isolated hepatocytes
        were elevated by WY-14,643 (50 mg/kg/day by gavage for up to 5 consecutive
        days) and by WY-14,643 (0.1%) or di(2-ethyl-hexyl)phthalate (DEHP) (1.2%)
        feeding (for up to 28 days), indicating peroxisome proliferation had occurred.
        DNA repair as unscheduled DNA synthesis (UDS) was measured autoradiographically
        as net nuclear grains following thymidine incorporation in primary hepatocyte
        cultures. Treatment of rats with WY-14,643 (gavage or feeding) or DEHP (feeding)
        did not induce UDS. Addition of 2-acetylaminofluorene to replicate cultures
        demonstrated that WY-14,643 or DEHP treatment did not prevent repair response.
        Additional cultures were treated with H2O2 (0.8 mM H2O2 3x at 1-h intervals)
        to evaluate the ability of UDS to detect any repair which may be induced by
        peroxisomal metabolism. H2O2 did not induce UDS at this concentration, nor
        did it prevent 2-acetylaminofluorene-induced repair. UDS was, however, observed
        in a separate experiment using a higher concentration of H2O2. In summary,
        a highly carcinogenic peroxisome proliferator did not induce UDS in the target
        cell for carcinogenesis in spite of peroxisome proliferation following in
        vivo treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Chemical
        Industry Institute of Toxicology, Research Triangle Park, NC 27709.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Smith-Oliver</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Butterworth</LastName><ForeName>B E</ForeName><Initials>BE</Initials></Author><Author
        ValidYN="Y"><LastName>Popp</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA 07945</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>9M98QLJ2DL</RegistryNumber><NameOfSubstance
        UI="D015073">2-Acetylaminofluorene</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance
        UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.-</RegistryNumber><NameOfSubstance UI="C028427">palmitoyl CoA oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.7</RegistryNumber><NameOfSubstance UI="D002332">Carnitine O-Acetyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015073" MajorTopicYN="N">2-Acetylaminofluorene</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002332" MajorTopicYN="N">Carnitine O-Acetyltransferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000502"
        MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1988</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1988</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1988</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3383337</ArticleId><ArticleId IdType="doi">10.1093/carcin/9.7.1179</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>'
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Access-Control-Expose-Headers:
      - X-RateLimit-Limit,X-RateLimit-Remaining
      Cache-Control:
      - private
      Connection:
      - Keep-Alive
      Content-Security-Policy:
      - upgrade-insecure-requests
      Content-Type:
      - text/xml; charset=UTF-8
      Date:
      - Thu, 05 Sep 2024 22:59:49 GMT
      Keep-Alive:
      - timeout=4, max=40
      NCBI-PHID:
      - 939B82323C96818500004DC2BB99797E.1.1.m_3
      NCBI-SID:
      - AB79C74EDF993B47_ADD9SID
      Referrer-Policy:
      - origin-when-cross-origin
      Server:
      - Finatra
      Set-Cookie:
      - ncbi_sid=AB79C74EDF993B47_ADD9SID; domain=.nih.gov; path=/; expires=Fri, 05
        Sep 2025 22:59:49 GMT
      Strict-Transport-Security:
      - max-age=31536000; includeSubDomains; preload
      Transfer-Encoding:
      - chunked
      X-RateLimit-Limit:
      - '10'
      X-RateLimit-Remaining:
      - '9'
      X-UA-Compatible:
      - IE=Edge
      X-XSS-Protection:
      - 1; mode=block
      content-encoding:
      - gzip
    status:
      code: 200
      message: OK
version: 1
